Developing a new resource for drug discovery: marine actinomycete bacteria
Top Cited Papers
- 1 December 2006
- journal article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 2 (12) , 666-673
- https://doi.org/10.1038/nchembio841
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Crystal Structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in Complex with the 20S Proteasome Reveal Important Consequences of β-Lactone Ring Opening and a Mechanism for Irreversible BindingJournal of the American Chemical Society, 2006
- Diversity of actinomycetes isolated from Challenger Deep sediment (10,898 m) from the Mariana TrenchExtremophiles, 2006
- Salinispora arenicola gen. nov., sp. nov. and Salinispora tropica sp. nov., obligate marine actinomycetes belonging to the family MicromonosporaceaeInternational Journal of Systematic and Evolutionary Microbiology, 2005
- The evolving role of natural products in drug discoveryNature Reviews Drug Discovery, 2005
- Marine actinomycetes as a source of novel secondary metabolitesAntonie van Leeuwenhoek, 2005
- Bioactive Microbial MetabolitesThe Journal of Antibiotics, 2005
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus SalinosporaAngewandte Chemie International Edition in English, 2003
- Lomaiviticins A and B, Potent Antitumor Antibiotics from Micromonospora lomaivitiensisJournal of the American Chemical Society, 2001
- The role of the chlorine substituents in the antibiotic vancomycin: preparation and characterization of mono- and didechlorovancomycinJournal of the American Chemical Society, 1985